(Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology

Trends in Biochemical Sciences

Volumn 32, Issue 10, 2007, Pages 457-468

  Merrill Jr , Alfred H ^a   Wang, May Dongmei ^a   Park, Meeyoung ^a   Sullards, M Cameron ^b  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; GLYCOSPHINGOLIPID; PHOSPHOLIPID;

CELL STRUCTURE; EUKARYOTE; HUMAN; LIPID ANALYSIS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VIRUS;

EUKARYOTIC CELLS; EXTRACELLULAR MATRIX; GLYCOLIPIDS; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PHOSPHOLIPIDS; PROKARYOTIC CELLS; SPHINGOLIPIDS; SYSTEMS BIOLOGY; VIRUSES;

EUKARYOTA; PROKARYOTA;

EID: 35348871278     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2007.09.004     Document Type: Review

References (92)

1. Auffray C., et al. From functional genomics to systems biology: concepts and practices. C. R. Biol. 326 (2003) 879-892
2. Aderem A. Systems biology: its practice and challenges. Cell 121 (2005) 511-513
3. McAnoy A.M., et al. Direct qualitative analysis of triacylglycerols by electrospray mass spectrometry using a linear ion trap. J. Am. Soc. Mass Spectrom. 16 (2005) 1498-1509
4. Merrill Jr. A.H., et al. Sphingolipidomics: High throughput, structure specific and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36 (2005) 207-224
5. Milne S., et al. Lipidomics: an analysis of cellular lipids by ESI-MS. Methods 39 (2006) 92-103
6. Fahy E., et al. A comprehensive classification system for lipids. J. Lipid Res. 46 (2005) 839-861
7. Sud M., et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 35 (2007) D527-D532
8. Guan Z., et al. Extraction and identification by mass spectrometry of undecaprenyl diphosphate-MurNAc-pentapeptide-GlcNAc from Escherichia coli. Anal. Biochem. 345 (2005) 336-339
9. Harkewicz R., et al. Arachidonate-derived Dihomoprostaglandin Production Observed in Endotoxin-stimulated Macrophage-like Cells. J. Biol. Chem. 282 (2007) 2899-2910
10. Zheng W., et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim. Biophys. Acta 1758 (2006) 1864-1884
11. Sullards M.C., and Merrill Jr. A.H. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE (2001) PL1
12. Esch S.W., et al. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 779-787
13. Han X., and Gross R.W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44 (2003) 1071-1079
14. Levery S.B. Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405 (2005) 300-369
15. Levery S.B., et al. Novel tri-and tetrasialosylpoly-N-acetyllactosaminyl gangliosides of human placenta: structure determination of pentadeca- and eicosaglycosylceramides by methylation analysis, fast atom bombardment mass spectrometry, and 1H NMR spectroscopy. Biochemistry 28 (1989) 7772-7781
16. Degroote S., et al. The cell biology of glycosphingolipids. Semin. Cell Dev. Biol. 15 (2004) 375-387
17. Ledeen R.W., and Wu G. Sphingolipids of the nucleus and their role in nuclear signaling. Biochim. Biophys. Acta 1761 (2006) 588-598
18. Sonnino S., et al. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem. Rev. 106 (2006) 2111-2125
19. Maggio B., et al. Biophysics of sphingolipids II. Glycosphingolipids: an assortment of multiple structural information transducers at the membrane surface. Biochim. Biophys. Acta 1758 (2006) 1922-1944
20. Freire E., et al. Sialic acid residues on astrocytes regulate neuritogenesis by controlling the assembly of laminin matrices. J. Cell Sci. 117 (2004) 4067-4076
21. Capela A., and Temple S. LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev. Biol. 291 (2006) 300-313
22. Schnaar R.L. Glycolipid-mediated cell-cell recognition in inflammation and nerve regeneration. Arch. Biochem. Biophys. 426 (2004) 163-172
23. Hanada K. Sphingolipids in infectious diseases. Jpn. J. Infect. Dis. 58 (2005) 131-148
24. Yoon S.J., et al. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18987-18991
25. Toledo M.S., et al. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J. Biol. Chem. 280 (2005) 16227-16234
26. Hakomori Si S.I. Inaugural Article: The glycosynapse. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 225-232
27. Hartel S., et al. Shape transitions and lattice structuring of ceramide-enriched domains generated by sphingomyelinase in lipid monolayers. Biophys. J. 88 (2005) 287-304
28. Goni F.M., and Alonso A. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta 1758 (2006) 1902-1921
29. Goni F.M., et al. Biophysics (and sociology) of ceramides. Biochem. Soc. Symp. 72 (2005) 177-188
30. Contreras F.X., et al. Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. Biophys. J. 88 (2005) 348-359
31. Siskind L.J., et al. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6 (2006) 118-125
32. Ogretmen B., and Hannun Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4 (2004) 604-616
33. Daido S., et al. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res. 64 (2004) 4286-4293
34. Scarlatti F., et al. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J. Biol. Chem. 279 (2004) 18384-18391
35. Hinkovska-Galcheva V., et al. Ceramide 1-phosphate, a mediator of phagocytosis. J. Biol. Chem. 280 (2005) 26612-26621
36. Gomez-Munoz A. Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim. Biophys. Acta 1758 (2006) 2049-2056
37. Gomez-Munoz A., et al. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J. Lipid Res. 45 (2004) 99-105
38. Pettus B.J., et al. Sphingolipids in inflammation: roles and implications. Curr. Mol. Med. 4 (2004) 405-418
39. Urs A.N., et al. Steroidogenic factor-1 is a sphingolipid binding protein. Mol. Cell. Endocrinol. 265-266 (2007) 174-178
40. Maceyka M., et al. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. Prostaglandins Other Lipid Mediat. 77 (2005) 15-22
41. Liliom K., et al. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem. J. 355 (2001) 189-197
42. Wang J.Q., et al. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J. Biol. Chem. 279 (2004) 45626-45633
43. Chester M.A. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids-recommendations 1997. Eur. J. Biochem. 257 (1998) 293-298
44. Hashimoto K., et al. A global representation of the carbohydrate structures: a tool for the analysis of glycan. Genome Inform. 16 (2005) 214-222
45. Karlsson K.-A. On the chemistry and occurrence of sphingolipid long-chain bases. Chem. Phys. Lipids 1 (1970) 6-43
46. Renkonen O., and Hirvisalo E.L. Structure of plasma sphingadienine. J. Lipid Res. 10 (1969) 687-693
47. Doering T., et al. Sphingolipid metabolism during epidermal barrier development in mice. J. Lipid Res. 43 (2002) 1727-1733
48. Merrill, A.H., Jr and Hannun, Y.A. (2000) Sphingolipid Metabolism and Cell Signaling. Part A & B. Methods in Enzymology (Vols. 311 and 312), Academic Press
49. Vukelic Z., et al. Analysis of human hippocampus gangliosides by fully-automated chip-based nanoelectrospray tandem mass spectrometry. J. Chromatogr. A. 1130 (2006) 238-245
50. Ivleva V.B., et al. Coupling thin-layer chromatography with vibrational cooling matrix-assisted laser desorption/ionization Fourier transform mass spectrometry for the analysis of ganglioside mixtures. Anal. Chem. 76 (2004) 6484-6491
51. Vukelic Z., et al. Screening and sequencing of complex sialylated and sulfated glycosphingolipid mixtures by negative ion electrospray Fourier transform ion cyclotron resonance mass spectrometry. J. Am. Soc. Mass Spectrom. 16 (2005) 571-580
52. Bielawski J., et al. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39 (2006) 82-91
53. Cheng H., et al. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 809-818
54. Valsecchi M., et al. Ceramide and sphingomyelin species of fibroblasts and neurons in culture. J. Lipid Res. 48 (2007) 417-424
55. Brugger B., et al. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2641-2646
56. Sommer U., et al. LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J. Lipid Res. 47 (2006) 804-814
57. Touboul D., et al. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. Anal. Bioanal. Chem. 382 (2005) 1209-1216
58. Fujiwaki T., et al. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 832 (2006) 97-102
59. Nakamura K., et al. Structural characterization of neutral glycosphingolipids by thin-layer chromatography coupled to matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight MS/MS. Anal. Chem. 78 (2006) 5736-5743
60. Tserng K.Y., and Griffin R. Studies of lipid turnover in cells with stable isotope and gas chromatograph-mass spectrometry. Anal. Biochem. 325 (2004) 344-353
61. Bederman I.R., et al. In vitro modeling of fatty acid synthesis under conditions simulating the zonation of lipogenic [13C]acetyl-CoA enrichment in the liver. J. Biol. Chem. 279 (2004) 43217-43226
62. Henning P.A., et al. Dynamic pathway modeling of sphingolipid metabolism. Conf. Proc. IEEE Eng. Med. Biol. Soc. 4 (2004) 2913-2916
63. Alvarez-Vasquez F., et al. Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature 433 (2005) 425-430
64. Merrill Jr. A.H. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem. 277 (2002) 25843-25846
65. Sullards M.C., et al. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 789-797
66. Merrill Jr. A.H., et al. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109 Suppl 2 (2001) 283-289
67. Venkataraman K., et al. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J. Biol. Chem. 277 (2002) 35642-35649
68. Koybasi S., et al. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279 (2004) 44311-44319
69. Senkal C.E., et al. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol. Cancer Ther. 6 (2007) 712-722
70. Pewzner-Jung Y., et al. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J. Biol. Chem. 281 (2006) 25001-25005
71. Chalfant C.E., et al. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J. Lipid Res. 45 (2004) 496-506
72. Pettus B.J., et al. Observation of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Rapid Commun. Mass Spectrom. 17 (2003) 1203-1211
73. Kolter T., et al. Combinatorial ganglioside biosynthesis. J. Biol. Chem. 277 (2002) 25859-25862
74. Furukawa K., et al. Glycosphingolipids in engineered mice: insights into function. Semin. Cell Dev. Biol. 15 (2004) 389-396
75. Yamashita T., et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3445-3449
76. Tadano-Aritomi K., et al. Kidney lipids in galactosylceramide synthase-deficient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids. J. Lipid Res. 41 (2000) 1237-1243
77. Kawano S., et al. Prediction of glycan structures from gene expression data based on glycosyltransferase reactions. Bioinformatics 21 (2005) 3976-3982
78. Schwarz A., and Futerman A.H. The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim. Biophys. Acta 1286 (1996) 247-267
79. Futerman A.H., and Riezman H. The ins and outs of sphingolipid synthesis. Trends Cell Biol. 15 (2005) 312-318
80. Tafesse F.G., et al. The multigenic sphingomyelin synthase family. J. Biol. Chem. 281 (2006) 29421-29425
81. Hanada K. Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol. Cell. Biochem. 286 (2006) 23-31
82. Sprong H., et al. Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum. Mol. Biol. Cell 14 (2003) 3482-3493
83. De Rosa M.F., et al. Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. J. Biol. Chem. 279 (2004) 7867-7876
84. Pitto M., et al. Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside. FEBS Lett. 383 (1996) 223-226
85. Tettamanti G., et al. Salvage pathways in glycosphingolipid metabolism. Biochimie 85 (2003) 423-437
86. Woods A.S., and Jackson S.N. Brain tissue lipidomics: direct probing using matrix-assisted laser desorption/ionization mass spectrometry. AAPS J. 8 (2006) E391-E395
87. Roy S., et al. Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry's disease. Ann. Pharm. Fr. 64 (2006) 328-334
88. Jackson S.N., et al. In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS. J. Am. Soc. Mass Spectrom. 18 (2007) 17-26
89. Sjovall P., et al. Mass spectrometric imaging of lipids in brain tissue. Anal. Chem. 76 (2004) 4271-4278
90. Borner K., et al. Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. Biochim. Biophys. Acta 1761 (2006) 335-344
91. Wiseman J.M., et al. Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. Angew. Chem. Int. Ed. Engl. 45 (2006) 7188-7192
92. Kraft M.L., et al. Phase separation of lipid membranes analyzed with high-resolution secondary ion mass spectrometry. Science 313 (2006) 1948-1951